Similar results achieved by TRK and PI3K inhibitors are unsurprising, as multiple signaling pathways may alter tumor cell metabolism and NRF2‐mediated NQO1 activation through different mechanisms [79, 81, 84]. This evidence concerns the gene NFE2L2 and neoplasm.